Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Regulatory News (SPH)

  • There is currently no data for SPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

14 Jun 2017 07:00

RNS Number : 0028I
Sinclair Pharma PLC
14 June 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Sinclair Pharma Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Toscafund Asset Management LLP

4. Full name of shareholder(s)  (if different from 3.):iv

 

TOSCA MID CAP

 

TOSCA OPPORTUNITY

 

THE PEGASUS FUND LIMITED

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

9/06/2017

6. Date on which issuer notified:

13/06/2017

7. Threshold(s) that is/are crossed orreached: vi, vii

24%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0033856740

127,296,386

127,296,386

122,837,275

0

122,837,275

0

24.38%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

122,837,275

24.38%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

N/A

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

None

14. Contact name:

Robert Lord

15. Contact telephone number:

020 7845 6100

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFJMPTMBABBJR
Date   Source Headline
24th Sep 20182:13 pmRNSForm 8.3 - Sinclair Pharma Plc
24th Sep 20181:58 pmBUSForm 8.3 - Sinclair Pharma plc - Amendment
24th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
24th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
24th Sep 20187:00 amBUSForm 8.3 - Sinclair Pharma plc
21st Sep 20183:48 pmRNSRobert Stuart Swanson-Form 8.3 Sinclair Pharma plc
21st Sep 20183:14 pmRNSForm 8.3 - Sinclair Pharma PLC
21st Sep 20182:18 pmRNSForm 8.3 - Sinclair Pharma PLC
21st Sep 20181:58 pmBUSForm 8.3 - Sinclair Pharma plc
21st Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
21st Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
20th Sep 20183:06 pmRNSForm 8.3 - Sinclair Pharma Plc
20th Sep 20182:55 pmBUSForm 8.3 - Sinclair Pharma plc
20th Sep 20182:42 pmRNSForm 8.3 - Sinclair Pharma
20th Sep 20182:34 pmRNSForm 8.3 - Sinclair Pharma Plc
20th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
20th Sep 20188:52 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
20th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma PLC
19th Sep 20183:29 pmRNSHolding(s) in Company
19th Sep 20182:29 pmRNSForm 8.3 - [Sinclair Pharma PLC]
19th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
19th Sep 201810:29 amRNSForm 8.3 - SINCLAIR PHARMA PLC
19th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
18th Sep 20182:55 pmRNSForm 8.3 - Sinclair Pharma Plc
18th Sep 20182:53 pmRNSForm 8.3 - Sinclair Pharma Plc
18th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
18th Sep 20189:36 amRNSForm 8.3 - SINCLAIR PHARMA PLC
18th Sep 20188:14 amRNSHolding(s) in Company
18th Sep 20188:02 amRNSRecommended Cash Offer for Sinclair Pharma plc
18th Sep 20188:01 amRNSRecommended Cash Offer for Sinclair Pharma plc
18th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
17th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
17th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
14th Sep 201812:08 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
14th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma plc
13th Sep 20181:49 pmRNSForm 8.3 - Sinclair Pharma plc
13th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
12th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
12th Sep 201810:35 amRNSForm 8.3 - SINCLAIR PHARMA PLC
12th Sep 20189:52 amRNSForm 8.3 - Sinclair Pharma Plc
12th Sep 20187:00 amRNSForm 8.3 - Sinclair Pharma PLC
11th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
11th Sep 20189:58 amRNSResponse to update re possible offer for Sinclair
11th Sep 20189:52 amRNSForm 8.3 - SINCLAIR PHARMA PLC
11th Sep 20189:46 amRNSUpdate re Possible Offer for Sinclair Pharma plc
10th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
7th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
6th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
5th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
4th Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.